Carbon footprint impact of the choice of inhalers for asthma and COPD.
In: Thorax, Jg. 75 (2020), Heft 1, S. 82-84
academicJournal
Zugriff:
In the 1990s, metered dose inhalers (MDIs) containing chlorofluorocarbons were replaced with dry-powder inhalers (DPIs) and MDIs containing hydrofluorocarbons (HFCs). While HFCs are not ozone depleting, they are potent greenhouse gases. Annual carbon footprint (CO2e), per patient were 17 kg for Relvar-Ellipta/Ventolin-Accuhaler; and 439 kg for Seretide-Evohaler/Ventolin-Evohaler. In 2017, 70% of all inhalers sold in England were MDI, versus 13% in Sweden. Applying the Swedish DPI and MDI distribution to England would result in an annual reduction of 550 kt CO2e. The lower carbon footprint of DPIs should be considered alongside other factors when choosing inhalation devices. [ABSTRACT FROM AUTHOR]
Copyright of Thorax is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Carbon footprint impact of the choice of inhalers for asthma and COPD.
|
---|---|
Autor/in / Beteiligte Person: | Janson, Christer ; Henderson, Richard ; Löfdahl, Magnus ; Hedberg, Martin ; Sharma, Raj ; Wilkinson, Alexander J. K. |
Zeitschrift: | Thorax, Jg. 75 (2020), Heft 1, S. 82-84 |
Veröffentlichung: | 2020 |
Medientyp: | academicJournal |
ISSN: | 0040-6376 (print) |
DOI: | 10.1136/thoraxjnl-2019-213744 |
Schlagwort: |
|
Sonstiges: |
|